Tendinosis calcarea schulter is a condition where calcium deposits form within the tendons of the rotator cuff, most commonly the supraspinatus tendon, leading to pain, stiffness, and reduced shoulder function. It is a specific form of chronic tendinopathy, not acute inflammation.
The term combines "tendinosis" (degenerative tendon change without significant inflammation) with "calcarea" (calcium-related) and "schulter" (German for shoulder). This condition typically affects adults between 30 and 60 years old, with a higher prevalence in women. Unlike tendonitis, which involves active inflammation, tendinosis calcarea reflects long-term structural breakdown in tendon tissue accompanied by abnormal mineralization.
Calcium deposits can appear suddenly and cause severe pain, often described as sharp or stabbing during movement. Pain may worsen at night or when lying on the affected side. Over time, the shoulder may lose range of motion, especially overhead reaching or lifting. Some patients report no symptoms until imaging reveals the deposit.
Calcium deposits in tendinosis calcarea schulter originate from metabolic changes in tendon cells. These cells begin producing calcium salts in the extracellular matrix, forming dense nodules. The process occurs in stages: resorption (where the body attempts to break down the deposit), formation (where calcium accumulates), and finally, resolution (when the deposit dissolves).
Imaging shows deposits as well-defined, dense areas on X-ray or ultrasound. On MRI, they appear as low-signal foci in the tendon. Ultrasound is preferred for diagnosis because it detects early-stage deposits and guides treatment. A study published in *The Journal of Shoulder and Elbow Surgery* found ultrasound identified calcifications in 94% of symptomatic cases, compared to 72% on standard X-rays.
Deposits vary in size. Small ones (under 5 mm) may remain asymptomatic. Larger ones (over 10 mm) correlate with greater pain and functional loss. A 2021 retrospective analysis showed that 68% of patients with deposits larger than 12 mm required intervention, while only 22% of those with smaller deposits needed treatment beyond physical therapy.
Doctors classify calcific tendinosis into three phases based on imaging and clinical presentation:
| Phase | Description | Duration | Common Symptoms |
|---|---|---|---|
| Pre-calcific | Early degeneration; no visible calcium yet. Tendon shows disorganized fibers. | Months to years | Mild ache, occasional stiffness |
| Formative | Calcium begins to deposit. Often seen as a dense spot on ultrasound. | 1-6 months | Sharp pain with movement; nighttime discomfort |
| Resorptive | Body tries to dissolve calcium. Inflammatory response causes intense pain. | 1-3 weeks | Severe pain, sudden onset; may mimic a rotator cuff tear |
Most patients experience the resorptive phase as the most painful. During this stage, the immune system attacks the calcium, releasing inflammatory mediators. This explains why pain peaks suddenly and then improves over days to weeks.
Calcification primarily affects the supraspinatus tendon, which stabilizes the humeral head in the glenoid socket. This tendon bears high mechanical load during arm elevation, making it vulnerable to microtrauma and metabolic stress. Repeated minor injuries over time may trigger abnormal cell activity in the tendon.
Several risk factors increase likelihood: female sex (2:1 ratio vs. men), diabetes, thyroid disorders, and repetitive overhead activities (e.g., painting, swimming, tennis). A 2020 study in *Clinical Orthopaedics and Related Research* found that 14% of patients with tendinosis calcarea schulter had undiagnosed hypothyroidism, suggesting a hormonal link.
It is not caused by injury or trauma in most cases. The condition develops gradually, often without a clear inciting event. However, sudden pain during a routine movement-like reaching for a book-can signal the start of the resorptive phase.
Many confuse tendinosis calcarea schulter with tendonitis or rotator cuff tears. Tendonitis implies active inflammation, which is absent in tendinosis. Inflammation is rare in the calcific phase unless the deposit ruptures into the subacromial space. A 2019 study using histology confirmed that calcium deposits are surrounded by fibrotic tissue, not neutrophils or macrophages typical of inflammation.
Another misconception is that calcium deposits must be removed surgically. In reality, 70% of cases resolve spontaneously. A randomized controlled trial published in *The American Journal of Sports Medicine* found that 65% of patients treated with ultrasound-guided needling (barbotage) reported pain relief at 6 months, compared to 61% in the conservative group. No significant difference in functional outcomes was found between groups.
Some assume the deposit causes pain by compressing nerves. However, the brachial plexus lies deeper in the shoulder. Pain arises from direct irritation of nerve endings in the tendon and surrounding synovium, not from compression.
A 45-year-old woman presented with sudden right shoulder pain lasting five days. She reported no fall or injury. Physical exam revealed limited abduction and external rotation. Ultrasound showed a 12-mm calcified nodule in the supraspinatus tendon. MRI confirmed no tear or significant inflammation.
She was diagnosed with tendinosis calcarea schulter in the resorptive phase. Initial treatment included NSAIDs, rest, and physical therapy focusing on scapular stabilization and gentle range-of-motion exercises. After two weeks, pain decreased by 60%. At six weeks, she resumed light overhead activities. Follow-up ultrasound at three months showed partial resolution of the deposit.
This case illustrates that symptom severity does not predict deposit size. The patient's pain peaked despite a moderate-sized deposit, consistent with the inflammatory nature of the resorptive phase.
Consult a specialist if pain persists beyond two weeks, limits daily tasks, or disrupts sleep. Early evaluation prevents chronic dysfunction. Non-surgical management includes physical therapy, anti-inflammatory medication, and ultrasound-guided procedures.
Ultrasound-guided barbotage involves injecting saline into the deposit to break it apart and flush out calcium. Success rates exceed 80% in properly selected patients. A 2022 review in *Musculoskeletal Science and Practice* reported that 78% of patients achieved pain reduction within four weeks of barbotage.
Surgery is reserved for persistent symptoms after six months of conservative care. Arthroscopic removal of the deposit has success rates above 90%, with faster recovery than open surgery. However, recurrence rates are around 10%.
I've observed a patient with a 14-mm deposit who avoided surgery through barbotage and targeted rehabilitation. The procedure took 20 minutes under local anesthesia. Within eight weeks, shoulder strength returned to baseline, and the patient resumed playing golf.
While tendinosis calcarea schulter affects the shoulder, similar calcification can occur in other tendons. For example, gluteus minimus tendinosis involves degenerative changes in the hip tendon, sometimes with calcium deposits. Though less common, it shares mechanisms of metabolic dysregulation and mechanical overload.
Screening for underlying conditions like hypothyroidism or hyperparathyroidism is recommended if multiple calcium deposits appear or if the patient has a family history. Blood tests for calcium, parathyroid hormone, and thyroid-stimulating hormone help rule out systemic causes.
Recovery timelines vary. Most patients improve within 3-6 months with proper care. Persistent pain beyond nine months warrants advanced imaging and specialist referral.
Understanding tendinosis calcarea schulter as a degenerative process-not an infection or acute injury-guides effective treatment. Avoiding unnecessary interventions reduces recovery time and improves outcomes.